Discovery & Development

Allergies pose a significant challenge to patients worldwide. How can we use novel immunotherapy approaches to lessen their therapeutic burden?

Can drugs change membrane protein function by altering the lipid bilayer environment? That’s what this researcher wanted to find out

SynaptixBio’s CEO discusses the personal road that led him to the fight against the rare disease H-ABC.

Can newly discovered antibodies help us do away with annual flu vaccinations?

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

Join the Curator for a look back on 12 months of top stories from cell and gene therapy’s avant garde.

Pfizer’s trial of a new medicine for COVID-19, produced with support from the US Department of Energy, could improve access to treatment.

Adoption of organ-on-a-chip technology is on the rise, but misconceptions remain prevalent, says Tomasz Kostrzewski of CN Bio.

Integrating digital technologies into your operations can make all the difference to the formulation process.

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.